Six essential digital capabilities to accelerate cell and gene therapy R&D

This solution guide highlights the most important software capabilities required to stay at the cutting edge of cell and gene therapy innovation. It will help teams think about how to centralize their data, collaborate across specialized functions, and reduce cycle time between key R&D milestones.


Cell and gene therapies have entered a new era of industrialization. In the race to address unmet medical needs with more targeted biopharmaceuticals, companies face a new set of challenges: data management and traceability, cross-functional collaboration, and decision management. Modern R&D teams are looking to enhance their digital foundation with capabilities that address these challenges.

This solution guide discusses:

Six essential digital capabilities that cell and gene therapies should be thinking about to accelerate their R&D, and a perspective on how Benchling’s R&D Cloud is delivering on these with a modern digital solution.

Join over 200,000 scientists using Benchling to power their biotech R&D

Helix Image